Sep 30, 2018

Xenon Pharmaceuticals Q3 2018 Earnings Report

EPS
-$0.63
Previous year: -$0.43
+46.5%
Cash and Equivalents
$88M
Previous year: $14.7M
+498.9%
Free Cash Flow
-$13.7M
Previous year: -$8.64M
+59.1%
Total Assets
$130M
Previous year: $46.4M
+181.4%

Xenon Pharmaceuticals

Xenon Pharmaceuticals